Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1625 1699
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18710091 | COMPOSITIONS AND METHODS FOR PRESERVING AND/OR RESTORING NEURAL FUNCTION | Non-Final OA | The Regents of the University of California |
| 18547462 | 2-SUBSTITUTED BICYCLO[1.1.1]PENTANES | Non-Final OA | The Trustees of Princeton University |
| 18333872 | REPURPOSED COMPOUND AS THERAPEUTIC FOR HPV-ASSOCIATED CANCERS | Final Rejection | The Chinese University of Hong Kong |
| 18784840 | PROANGIOGENIC PROTEIN COCKTAILS DELIVERED IN CUSTOM BIOMATERIALS TO REVASCULARIZE ISCHEMIC TISSUE | Non-Final OA | Brown University |
| 18037751 | INHIBITORS OF IGF2BP1-RNA BINDING | Final Rejection | THE PENN STATE RESEARCH FOUNDATION |
| 18489722 | THERAPEUTIC AGENT FOR SOLID CANCERS, WHICH COMPRISES AXL INHIBITOR AS ACTIVE INGREDIENT | Non-Final OA | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy